Avita Medical
RCEL
Avita Medical (RCEL) Fails to deliver data
Key failure to deliver metrics for Avita Medical :
- Last SEC data release: 2024-05-31
- Last 15 days FTD volume: $0.35 M
- Last 3 months FTD volume: $0.81 M
- Last year FTD volume: $3.1 M
Failures to deliver for Avita Medical (RCEL) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Avita Medical (RCEL) - since 2020
Volume in USD (price x number of shares), data since 2020Avita Medical (RCEL) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $1.64 M | -18.49% |
| 2023 | $2.01 M | -34.38% |
| 2022 | $3.06 M | -73.09% |
| 2021 | $11.39 M | 135.77% |
| 2020 | $4.83 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Organovo ONVO | $3.74 M | $4.42 M | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | N/A | $0.27 B | 🇬🇧 UK |
 Novavax NVAX | $51.05 M | $0.31 B | 🇺🇸 USA |
 Novocure
NVCR | $1.15 M | $7.34 M | Jersey |